WALTHAM, Mass.--(BUSINESS WIRE)-- Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, is unveiling the Signals ClinicalTM solution, a software-as-a ...
WALTHAM, Mass.--(BUSINESS WIRE)-- Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, will launch Signals SynergyTM, a software solution designed ...
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals Software, is introducing the new Signals ChemDraw ® offering, ...
Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI(TM) software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity's Harmony(TM) and ...
Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions ACD/Labs brings deep expertise in supporting ...
Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals Software, will launch its Signals One(TM), a unified software platform evolved from the Company's existing ...
Revvity, Inc. RVTY is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by its solid third-quarter 2024 performance and focus on artificial ...
Revvity, Inc. RVTY recently introduced Signals Xynthetica, a next-generation AI-augmented design platform aimed at transforming molecular and materials discovery across scientific industries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback